Prostate Cancer
📧 Sign up to get email alerts when something new happens for Prostate Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2013-02-01Clinical Trial Update: Ketoconazole, Dexamethasone, and Hydrocortisone in Treating Patients With Prostate Cancer That Did Not Respond to Androgen-Deprivation Therapy [NA]
A Roswell Park Cancer Institute study evaluating a combination of ketoconazole, dexamethasone, and hydrocortisone for patients with prostate…
-
CLINICAL_TRIALS trial_result · 2013-01-31Clinical Trial Update: Vaccine Therapy Plus QS21 in Treating Patients With Progressive Prostate Cancer [Phase 1]
Phase 1 clinical trial updating the evaluation of a vaccine therapy combined with the QS-21 adjuvant for progressive prostate cancer; the st…
-
CLINICAL_TRIALS trial_result · 2013-01-31Clinical Trial Update: Study of Coronary Heart Disease (CHD) & Heart Failure (HF) Risk in Prostate Cancer Patients, Taking Casodex or Not
A completed study evaluated the risk of coronary heart disease and heart failure in prostate cancer patients treated with Casodex (bicalutam…
-
CLINICAL_TRIALS trial_result · 2013-01-31Clinical Trial Update: Vaccine Therapy Plus QS21 in Treating Patients With Prostate Cancer [Phase 1]
This entry reports the completion of a Phase 1 clinical trial evaluating Vaccine Therapy in combination with QS-21 for prostate cancer.
-
CLINICAL_TRIALS trial_result · 2013-01-29Clinical Trial Update: Rehabilitation After Radiotherapy for Prostate Cancer [Phase 2, Phase 3]
Clinical trial update noting the completion of Phase 2 and Phase 3 studies investigating rehabilitation after radiotherapy for prostate canc…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-01-28Clinical Trial Update: A Phase II Trial of Calcitriol and Naproxen in Patients With Recurrent Prostate Cancer [Phase 2]
Phase II trial of Calcitriol and Naproxen in recurrent prostate cancer was terminated.
-
FDA label_change · 2013-01-25FDA Approved: VABRINTY — Supplemental Application (URONOVA PHARMACEUTICALS, INC.)
FDA approved a supplemental application for VABRINTY (leuprolide acetate) from Uronova Pharmaceuticals, resulting in labeling changes for th…
-
CLINICAL_TRIALS trial_result · 2013-01-25Clinical Trial Update: SB-715992 in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Docetaxel or Paclitaxel [Phase 2]
A Phase 2 trial evaluating SB-715992 in metastatic prostate cancer that progressed after docetaxel or paclitaxel has completed.
-
CLINICAL_TRIALS trial_result · 2013-01-25Clinical Trial Update: Broxuridine Plus Surgery in Treating Patients With Stage I or Stage II Prostate Cancer [Phase 2]
Phase 2 clinical trial evaluating broxuridine plus surgery for Stage I and Stage II prostate cancer has completed.
-
CLINICAL_TRIALS trial_result · 2013-01-24Clinical Trial Update: GTI-2040 and Docetaxel in Treating Patients With Recurrent, Metastatic, or Unresectable Locally Advanced Non-Small Cell Lung Cancer, Prostate Cancer, or Other Solid Tumors [Phase 1, Phase 2]
Phase 1/2 trial evaluating GTI-2040 with docetaxel in patients with recurrent/metastatic non-small cell lung cancer or prostate cancer; the …
-
CLINICAL_TRIALS research · 2013-01-24Clinical Trial Update: Vaccine Therapy in Treating Patients With Advanced Adenocarcinoma of the Prostate (Prostate Cancer) [Phase 2]
Phase 2 clinical trial update on a vaccine therapy for advanced adenocarcinoma of the prostate; the trial has been terminated.
-
CLINICAL_TRIALS trial_result · 2013-01-23Clinical Trial Update: Vaccine Therapy in Treating Patients With Recurrent Prostate Cancer [Phase 2]
A Phase 2 vaccine therapy trial for recurrent prostate cancer has completed.
-
CLINICAL_TRIALS research · 2013-01-23Clinical Trial Update: Protocol for the Specified Clinical Experience Investigation on the Single Use of Casodex® Tablet 80 mg
This document provides a protocol update for a clinical trial of a single-use 80 mg Casodex tablet (bicalutamide) in prostate cancer. The tr…
-
CLINICAL_TRIALS trial_result · 2013-01-21Clinical Trial Update: PET/CT Imaging for Radiation Dosimetry, Plasma Pharmacokinetics, Biodistribution, Safety and Tolerability and Diagnostic Performance of BAY86-7548 in Patients With Prostate Cancer and Healthy Volunteers [Phase 1]
Phase 1 clinical trial evaluating BAY86-7548 for PET/CT imaging in prostate cancer patients and healthy volunteers, assessing radiation dosi…
-
CLINICAL_TRIALS trial_result · 2013-01-21Clinical Trial Update: PET/CT (Positron Emission Tomography/Computed Tomography) Imaging for Safety and Tolerability and Diagnostic Performance of BAY1075553 in Patients With Prostate Cancer and Healthy Volunteers [Phase 1]
This completed Phase 1 trial evaluated PET/CT imaging with BAY1075553 to assess safety, tolerability, and diagnostic performance in patients…
-
CLINICAL_TRIALS trial_result · 2013-01-18Clinical Trial Update: Degarelix as Second-Line Hormonal Treatment After Prostate-specific Antigen (PSA)-Failure in GnRH Agonist Treated Patients With Prostate Cancer [Phase 2]
Phase 2 trial evaluating degarelix as second-line hormonal therapy after PSA failure in men previously treated with GnRH agonists for prosta…
-
CLINICAL_TRIALS trial_result · 2013-01-18Clinical Trial Update: CT Scans in Guiding the Treatment of Patients With Prostate Cancer Who Are Undergoing Radiation Therapy [Phase 2]
Phase 2 trial assessing the use of CT scans to guide radiation therapy decisions in patients with prostate cancer. The study status is compl…
-
CLINICAL_TRIALS trial_result · 2013-01-18Clinical Trial Update: ET 743 (Yondelis) in Men With Advanced Prostate Cancer [Phase 2]
A Phase 2 trial evaluating ET-743 (Yondelis) in men with advanced prostate cancer has completed. Results have been posted.
-
CLINICAL_TRIALS trial_result · 2013-01-18Clinical Trial Update: Testosterone in Treating Patients With Progressive Prostate Cancer That No Longer Responds to Hormone Therapy [Phase 1]
A Phase 1 clinical trial evaluated the use of testosterone to treat men with progressive prostate cancer that no longer responds to hormone …
-
CLINICAL_TRIALS research · 2013-01-17Clinical Trial Update: Choline-PET for Evaluating the Incidence of Nodal Metastases Among Newly Diagnosed Patients of Prostate Cancer [NA]
A clinical trial update evaluating choline-PET imaging to assess the incidence of nodal metastases in newly diagnosed prostate cancer patien…
-
CLINICAL_TRIALS trial_result · 2013-01-16Clinical Trial Update: Docetaxel in Treating Older Patients With Metastatic Breast, Lung, or Prostate Cancer [Phase 2]
A Phase 2 trial evaluating docetaxel in older patients with metastatic breast cancer, lung cancer, or prostate cancer has completed.
-
CLINICAL_TRIALS trial_result · 2013-01-16Clinical Trial Update: Photodynamic Therapy With Lutetium Texaphyrin in Treating Patients With Locally Recurrent Prostate Cancer [Phase 1]
Phase 1 clinical trial assessing the safety and dosing of photodynamic therapy with lutetium texaphyrin in patients with locally recurrent p…
-
CLINICAL_TRIALS trial_result · 2013-01-16Clinical Trial Update: Combination Chemotherapy Plus Warfarin in Treating Patients With Prostate Cancer [Phase 2]
A Phase 2 trial evaluated combining chemotherapy with warfarin for patients with prostate cancer and thromboembolism; the study status is co…
-
CLINICAL_TRIALS research · 2013-01-11Clinical Trial Update: Participation in Procurement of Tissue, Serum, Plasma, Cell Bank, DNA and RNA Samples, and Urine for Biological Studies Related to Prostate Cancer and Prostate Cancer Treatment Follow Up
A Mayo Clinic-led clinical trial completed its participation in procuring biological samples (tissue, serum, plasma, cell banks, DNA, RNA, a…
-
CLINICAL_TRIALS trial_result · 2013-01-08Clinical Trial Update: Neoadjuvant CCI-779 Followed By Radical Prostatectomy in Treating Patients With Newly Diagnosed Prostate Cancer Who Have a High Risk of Relapse [Phase 2]
A Phase 2 trial evaluated neoadjuvant temsirolimus (CCI-779) followed by radical prostatectomy in men with newly diagnosed high-risk prostat…